These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 9284729)

  • 1. Procollagen propeptide and pyridinium cross-links as markers of type I collagen turnover: sex- and age-related changes in healthy children.
    Zanze M; Souberbielle JC; Kindermans C; Rossignol C; Garabedian M
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2971-7. PubMed ID: 9284729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of bone resorption with a new marker of collagen degradation in patients with metabolic bone disease.
    Garnero P; Gineyts E; Riou JP; Delmas PD
    J Clin Endocrinol Metab; 1994 Sep; 79(3):780-5. PubMed ID: 8077361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Different responses of free and peptide-bound cross-links to vitamin D and calcium supplementation in elderly women with vitamin D insufficiency.
    Kamel S; Brazier M; Rogez JC; Vincent O; Maamer M; Desmet G; Sebert JL
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3717-21. PubMed ID: 8855828
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatment.
    Garnero P; Shih WJ; Gineyts E; Karpf DB; Delmas PD
    J Clin Endocrinol Metab; 1994 Dec; 79(6):1693-700. PubMed ID: 7989477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-sectional evaluation of bone metabolism in men.
    Szulc P; Garnero P; Munoz F; Marchand F; Delmas PD
    J Bone Miner Res; 2001 Sep; 16(9):1642-50. PubMed ID: 11547833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of age, menopause and osteoporosis on free, peptide-bound and total pyridinium crosslink excretion.
    Del Campo MT; González-Casaus ML; Aguado P; Bernad M; Carrera F; Martínez ME
    Osteoporos Int; 1999; 9(5):449-54. PubMed ID: 10550465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Bone resorption markers].
    Takahashi M; Inoue T
    Rinsho Byori; 1996 May; 44(5):415-22. PubMed ID: 8676559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urinary markers of bone turnover in healthy children and adolescents: age-related changes and effect of puberty.
    Mora S; Prinster C; Proverbio MC; Bellini A; de Poli SC; Weber G; Abbiati G; Chiumello G
    Calcif Tissue Int; 1998 Nov; 63(5):369-74. PubMed ID: 9799819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel serum markers of bone resorption: clinical assessment and comparison with established urinary indices.
    Woitge HW; Pecherstorfer M; Li Y; Keck AV; Horn E; Ziegler R; Seibel MJ
    J Bone Miner Res; 1999 May; 14(5):792-801. PubMed ID: 10320528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxy-terminal propeptide of human type I collagen and pyridinium cross-links as markers of bone growth in infants 1 to 18 months of age.
    Lieuw-A-Fa M; Sierra RI; Specker BL
    J Bone Miner Res; 1995 Jun; 10(6):849-53. PubMed ID: 7572307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship of bone turnover to bone density and fractures.
    Melton LJ; Khosla S; Atkinson EJ; O'Fallon WM; Riggs BL
    J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary markers of type I collagen degradation in the dog.
    Allen MJ; Allen LC; Hoffmann WE; Richardson DC; Breur GJ
    Res Vet Sci; 2000 Oct; 69(2):123-7. PubMed ID: 11020362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary excretion of cross-linked N-telopeptides of type 1 collagen to assess bone resorption in infants from birth to 1 year of age.
    Lapillonne A; Travers R; DiMaio M; Salle BL; Glorieux FH
    Pediatrics; 2002 Jul; 110(1 Pt 1):105-9. PubMed ID: 12093954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intensive chemotherapy on bone and collagen turnover and the growth hormone axis in children with acute lymphoblastic leukemia.
    Crofton PM; Ahmed SF; Wade JC; Stephen R; Elmlinger MW; Ranke MB; Kelnar CJ; Wallace WH
    J Clin Endocrinol Metab; 1998 Sep; 83(9):3121-9. PubMed ID: 9745414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of biochemical markers of bone turnover in Paget disease treated with pamidronate and a proposed model for the relationships between measurements of the different forms of pyridinoline cross-links.
    Randall AG; Kent GN; Garcia-Webb P; Bhagat CI; Pearce DJ; Gutteridge DH; Prince RL; Stewart G; Stuckey B; Will RK; Retallack RW; Price RI; Ward L
    J Bone Miner Res; 1996 Aug; 11(8):1176-84. PubMed ID: 8854254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry.
    Eriksen EF; Charles P; Melsen F; Mosekilde L; Risteli L; Risteli J
    J Bone Miner Res; 1993 Feb; 8(2):127-32. PubMed ID: 8442431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D supplementation to healthy children does not affect serum osteocalcin or markers of type I collagen turnover.
    Schou AJ; Heuck C; Wolthers OD
    Acta Paediatr; 2003 Jul; 92(7):797-801. PubMed ID: 12892157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-line therapy with thalidomide, dexamethasone and zoledronic acid decreases bone resorption markers in patients with multiple myeloma.
    Tosi P; Zamagni E; Cellini C; Parente R; Cangini D; Tacchetti P; Perrone G; Ceccolini M; Boni P; Tura S; Baccarani M; Cavo M
    Eur J Haematol; 2006 May; 76(5):399-404. PubMed ID: 16480429
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Collagen N-telopeptide excretion in men: the effects of age and intrasubject variability.
    Orwoll ES; Bell NH; Nanes MS; Flessland KA; Pettinger MB; Mallinak NJ; Cain DF
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3930-5. PubMed ID: 9814471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
    Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.